Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds

By Yahoo! Finance | Nov 23, 2024 at 11:05 AM EST

The oncology market is experiencing significant growth, with radiopharmaceuticals showing potential for generating billions in revenue. The global oncology market is projected to exceed $500 billion by 2032, driven by new therapies and research advancements.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.